Log in
NASDAQ:TRIL

Trillium Therapeutics SEC Filings & 10K Form

$14.21
+0.66 (+4.87 %)
(As of 09/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$13.41
Now: $14.21
$14.30
50-Day Range
$8.33
MA: $11.72
$16.00
52-Week Range
$0.24
Now: $14.21
$16.89
Volume1.47 million shs
Average Volume3.16 million shs
Market Capitalization$1.40 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.23

SEC Filings

Trillium Therapeutics (NASDAQ:TRIL) SEC Filings

DateFilerForm TypeView
09/18/2020
6:19 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2020
3:30 PM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/11/2020
3:45 PM
Trillium Therapeutics (Filer)
Form 424B5
09/10/2020
7:23 PM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/09/2020
3:15 PM
Trillium Therapeutics (Filer)
Form 424B5
09/09/2020
3:01 PM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/09/2020
3:01 PM
Trillium Therapeutics (Filer)
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/08/2020
3:05 PM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/12/2020
6:04 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/30/2020
6:29 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/06/2020
6:10 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2020
7:00 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/26/2020
6:01 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/13/2020
6:04 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/11/2020
3:13 PM
MORGAN STANLEY (Filed by)
Trillium Therapeutics (Subject)
Form SC 13G/A
05/06/2020
6:12 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/05/2020
4:21 PM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/04/2020
11:15 PM
Trillium Therapeutics (Filer)
Form EFFECT
04/23/2020
3:48 PM
Trillium Therapeutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
04/08/2020
6:08 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2020
6:09 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2020
6:06 AM
Trillium Therapeutics (Filer)
Form 40-F
Registration statement pursuant to Section 12 or annual report pursuant to Section 13(a) or 15(d)
02/13/2020
1:25 PM
MORGAN STANLEY (Filed by)
Trillium Therapeutics (Subject)
Form SC 13G/A
02/07/2020
6:00 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/04/2020
4:19 PM
Growth Equity Opportunities V, LLC (Filed by)
Trillium Therapeutics (Subject)
Form SC 13D/A
01/29/2020
6:48 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/23/2020
3:36 PM
Trillium Therapeutics (Filer)
Form SUPPL
01/23/2020
3:28 PM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/23/2020
8:01 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/22/2020
3:02 PM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/21/2020
3:52 PM
Trillium Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G
01/21/2020
10:27 AM
Empery Asset Management, LP (Filed by)
Trillium Therapeutics (Subject)
Form SC 13G/A
01/16/2020
7:01 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/07/2020
7:29 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/31/2019
3:24 PM
MORGAN STANLEY (Filed by)
Trillium Therapeutics (Subject)
Form SC 13G
11/14/2019
6:14 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2019
6:10 AM
Trillium Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/06/2019
6:15 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/22/2019
8:00 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/08/2019
6:01 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/25/2019
6:03 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2019
6:03 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/13/2019
6:06 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/24/2019
6:03 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/02/2019
6:07 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2019
12:00 PM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/13/2019
6:01 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2019
6:01 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2019
6:00 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2019
6:00 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2019
6:06 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/02/2019
6:14 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2019
4:01 PM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/11/2019
4:04 PM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/11/2019
4:03 PM
Trillium Therapeutics (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/08/2019
4:00 PM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/04/2019
3:50 PM
Empery Asset Management, LP (Filed by)
Trillium Therapeutics (Subject)
Form SC 13G
03/04/2019
2:45 PM
Growth Equity Opportunities V, LLC (Filed by)
Trillium Therapeutics (Subject)
Form SC 13D/A
02/25/2019
4:05 PM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/25/2019
4:03 PM
Trillium Therapeutics (Filer)
Form SUPPL
02/22/2019
8:01 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/21/2019
7:37 PM
Trillium Therapeutics (Filer)
Form SUPPL
02/21/2019
3:05 PM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2019
3:03 PM
Cormorant Asset Management, LP (Filed by)
Trillium Therapeutics (Subject)
Form SC 13G/A
02/14/2019
1:39 PM
Matrix Capital Management Company, LP (Filed by)
Trillium Therapeutics (Subject)
Form SC 13G/A
02/12/2019
10:05 AM
MORGAN STANLEY (Filed by)
Trillium Therapeutics (Subject)
Form SC 13G/A
01/10/2019
2:39 PM
AWM Investment Company, Inc. (Filed by)
Trillium Therapeutics (Subject)
Form SC 13G/A
12/21/2018
3:03 PM
MORGAN STANLEY (Filed by)
Trillium Therapeutics (Subject)
Form SC 13G
12/03/2018
6:00 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2018
6:00 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/28/2018
6:19 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2018
6:00 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/12/2018
6:15 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/30/2018
8:31 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/08/2018
6:00 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/25/2018
9:34 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/18/2018
8:52 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/15/2018
6:00 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/14/2018
6:00 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/07/2018
6:02 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/05/2018
6:01 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/31/2018
11:15 PM
Trillium Therapeutics (Filer)
Form EFFECT
05/16/2018
4:16 PM
Trillium Therapeutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
05/11/2018
6:05 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/18/2018
6:00 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/12/2018
6:11 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/10/2018
6:12 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/04/2018
4:23 PM
Trillium Therapeutics (Filer)
Form 40-F/A
03/20/2018
6:00 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/09/2018
6:02 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/09/2018
6:01 AM
Trillium Therapeutics (Filer)
Form 40-F
Registration statement pursuant to Section 12 or annual report pursuant to Section 13(a) or 15(d)
02/09/2018
6:01 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/06/2018
3:12 PM
JANUS CAPITAL MANAGEMENT LLC (Filed by)
Trillium Therapeutics (Subject)
Form SC 13G/A
01/17/2018
6:15 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2018
11:15 PM
Trillium Therapeutics (Filer)
Form EFFECT
01/08/2018
2:00 PM
Trillium Therapeutics (Filer)
Form F-10/A
12/15/2017
2:02 PM
Trillium Therapeutics (Subject)
Form F-X
Appointment of agent for service of process and undertaking  
12/15/2017
1:31 PM
Trillium Therapeutics (Filer)
Form F-10
Registration statement for securities of certain Canadian issuers  
12/12/2017
2:55 PM
Trillium Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
12/11/2017
7:00 AM
Trillium Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
This page was last updated on 10/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.